Cedars-Sinai Biomanufacturing Center
Zac Grodzinski is an accomplished professional with extensive experience in process development and manufacturing within the biomanufacturing sector, currently serving as Program Manager at Cedars-Sinai Biomanufacturing Center since September 2020. In this role, Zac manages a GMP Manufacturing and Process Development team across multiple cell therapy programs, ensuring seamless transitions from technology transfer to clinical manufacturing. Previous positions at Cedars-Sinai include Project Manager and Biomedical Specialist, where Zac oversaw tech transfer initiatives, designed manufacturing strategies, and implemented ERP and CMMS systems. Zac's background in research spans across various roles at Cedars-Sinai, Sunnybrook Health Sciences Centre, and the University of Toronto, focusing on drug development and biomaterials. Zac holds an MBA from Boston University, a Master's in Biomedical Engineering, and a Bachelor's in Materials Science and Engineering from the University of Toronto, complemented by a credential from Harvard Business School Online.
This person is not in any teams
Cedars-Sinai Biomanufacturing Center
1 followers
• The Cedars-Sinai Biomanufacturing Center (CBC) is a new 25,000 square feet, state-of-the-art biomanufacturing facility located in West Hollywood, California. • Manufacturing the next generation of cell and gene therapies for human IND-enabling clinical trials. • cGMP cell manufacturing facility housing multiple cleanroom cell production suites and process development laboratories. • Combined expertise in a cGMP-compliant approach to manufacture cells at scale with innovative technologies and equipment. • Transferring laboratory protocols to cGMP, up-scaling of processes and achieving Food and Drug Administration standards to bring innovative cell therapy solutions to researchers and translational scientists. • World-class expertise in stem cell (iPSC) biology, gene editing and bioprocessing. • Supporting California Institute for Regenerative Medicine (CIRMN) programs, CBC is providing a much-needed cell biomanufacturing center in California